Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biological Age”

343 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 343 results

Post-approval studies (Phase 4)Study completedNCT01430611
What this trial is testing

Study of Sanofi Pasteur and Lanzhou Institute's Meningococcal (Group A and C) Polysaccharide Vaccine in Children

Who this might be right for
Meningococcal DiseaseMeningitis
Sanofi Pasteur, a Sanofi Company 666
Testing effectiveness (Phase 2)Study completedNCT00129116
What this trial is testing

3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 388
Large-scale testing (Phase 3)Study completedNCT00464815
What this trial is testing

Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 11-17 Year-Old Subjects

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 1,025
Large-scale testing (Phase 3)Study completedNCT00696891
What this trial is testing

Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults

Who this might be right for
Hepatitis B
GlaxoSmithKline 380
Testing effectiveness (Phase 2)Study completedNCT03636906
What this trial is testing

Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 201
Large-scale testing (Phase 3)Study completedNCT00473668
What this trial is testing

Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib

Who this might be right for
Whole Cell PertussisHaemophilus Influenzae Type bTetanus+2 more
GlaxoSmithKline 300
Testing effectiveness (Phase 2)Study completedNCT00429481
What this trial is testing

Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine at Different Viral Concentrations in Healthy Infants

Who this might be right for
Hepatitis B
GlaxoSmithKline 2,464
Testing effectiveness (Phase 2)Study completedNCT03204227
What this trial is testing

Safety of Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) in Children From 9-24 Months of Age

Who this might be right for
Japanese Encephalitis
National Institute of Hygiene and Epidemiology, Vietnam 220
Large-scale testing (Phase 3)Study completedNCT00345683
What this trial is testing

Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age.

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 4,021
Early research (Phase 1)Study completedNCT01096056
What this trial is testing

Trial to Evaluate the Safety and the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Healthy Children

Who this might be right for
Influenza
GlaxoSmithKline 40
Large-scale testing (Phase 3)Study completedNCT06025695
What this trial is testing

Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 Weeks

Who this might be right for
Gastroenteritis
GlaxoSmithKline 2,000
Testing effectiveness (Phase 2)Study completedNCT01061541
What this trial is testing

Immunogenicity, Safety & Reactogenicity of GSK Vaccine Tritanrix™-HepB/Hib2.5 Compared to GSK Vaccine Tritanrix™-HepB/Hiberix™

Who this might be right for
Haemophilus Influenzae Type b
GlaxoSmithKline 192
Large-scale testing (Phase 3)Study completedNCT01235975
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine Given as One Dose to Healthy Subjects Above 56 Years

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 400
Not applicableStudy completedNCT01917591
What this trial is testing

Healing of Punch Graft Wounds. Comparative Study Between MariGen and Oasis: a Non-inferiority Study

Who this might be right for
Punch Biopsy WoundsHealing Times
Kerecis Ltd. 81
Testing effectiveness (Phase 2)Study completedNCT00307567
What this trial is testing

Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488

Who this might be right for
Acellular PertussisTetanusHepatitis B+3 more
GlaxoSmithKline 689
Testing effectiveness (Phase 2)Study completedNCT04789577
What this trial is testing

Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and Older

Who this might be right for
Influenza, Human
GlaxoSmithKline 833
Testing effectiveness (Phase 2)Study completedNCT01001169
What this trial is testing

Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese Children

Who this might be right for
Influenza
GlaxoSmithKline 60
Testing effectiveness (Phase 2)Study completedNCT00133445
What this trial is testing

Pentavalent DTaP-Hep B-IPV

Who this might be right for
DiphtheriaHepatitis BPoliomyelitis+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 5
Large-scale testing (Phase 3)Study completedNCT00327184
What this trial is testing

Primary & Booster Study in Infants to Demonstrate Non-inferiority, Persistence & Immunogenicity of Hib-MenC Vaccine

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 709
Testing effectiveness (Phase 2)Study completedNCT01679665
What this trial is testing

Systems Biology of Vaccination for EV71 Vaccine in Humans

Who this might be right for
Systems BiologyEarly GeneEV71 Vaccine
Jiangsu Province Centers for Disease Control and Prevention 72
Load More Results